NCT06132620View on ClinicalTrials.gov

Clinical Efficacy of Qingxin Zishen Decoction in Treating Menopausal Syndrome and Neuroendocrine Mechanism of Regulating KNDy Neurons

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Menopause
Interventions
DRUG

Femoston

"Fenmorphone (this product is a compound preparation, estradiol tablets contain estradiol 2mg; Estradiol dydrogesterone tablets contain estradiol 2 mg and dydrogesterone 10 mg).~Usage: 1 time/day: 1 tablet orally every day, every 28 days as a course of treatment."

DRUG

Qingxin Zishen Decoction

Qingxin Zi Kidney Decoction is a traditional Chinese medicine decoction, after regular decoction, 1 dose/day, divided into 2 doses.

Trial Locations (1)

Unknown

Yuxin Zhou, Nanjing

All Listed Sponsors
lead

Yun Chen

OTHER

NCT06132620 - Clinical Efficacy of Qingxin Zishen Decoction in Treating Menopausal Syndrome and Neuroendocrine Mechanism of Regulating KNDy Neurons | Biotech Hunter | Biotech Hunter